Fenofibrate Role in Breast Cancer Patients

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

August 1, 2024

Study Completion Date

August 5, 2024

Conditions
Breast Cancer
Interventions
DRUG

Placebo

25 patients will receive four cycle of AC followed by paclitaxel 80 mg/m2 weekly for 12 week

DRUG

Fenofibrate 160mg

25 patients will receive four cycle of AC followed by paclitaxel 80 mg/m2 weekly for 12 week in addition to 160mg fenofibrate once daily for 3 month.

Trial Locations (1)

31527

Damanhour Oncology Center, Damanhūr

All Listed Sponsors
lead

Damanhour University

OTHER